AHBARx Tirzepatide Review: $349/Month, Consult and Shipping Included (2026)

AHBARx sells compounded tirzepatide at $349 a month, month to month, and it puts that figure on the product page rather than behind a quiz — no account, no email address, nothing to submit before you can read it. The $50 provider consultation and the $25 shipping both appear at checkout as Included rather than as charges bolted on at the end. Every figure below was read live on 1 September 2026 from AHBARx's own pages.¹

What AHBARx costs, and what the price covers

One month's supply is $349, delivered monthly. The prepay rungs are $949 for three months and $1,799 for six, both struck against a permanently higher figure, which anchors rather than saves. The checkout itemizes the consultation at $50 and discreet shipping at $25, marks both Included, and promises money back if you are not approved — a clean way to present a price in a category that mostly reveals one after an intake.

The pharmacy it names, and a letter against that pharmacy

AHBARx names AnazaoHealth as its pharmacy, and names Beluga Health and Qualiphy as the provider groups behind the prescriptions. That disclosure comes with something attached. AnazaoHealth Corporation, the pharmacy AHBARx names on its own pages, received an FDA warning letter in August 2021; FDA publishes the letter itself, and it does not name AHBARx.² We say it because a letter against the facility that will compound your vial is decision-relevant, and we say its limit just as plainly: it is an action against a pharmacy, not against this telehealth program. Note too that AHBARx's Help Center calls AnazaoHealth a provider group while FDA's letter identifies it as a pharmacy, and no 503A or 503B designation appears anywhere on the site.

The brand-vs-compounded question

This is compounded tirzepatide, not Zepbound. A compounded drug is pharmacy-made, is not itself an FDA-approved finished product, and was not what the pivotal trials tested. Our guide to whether compounded tirzepatide is still legal in 2026 sets out where that stands now the shortage has ended.

How the care model holds up

The strengths are the published price, the named pharmacy, a checkout state selector covering all fifty states and the District of Columbia, and a refund if a clinician declines you. The weaknesses are in the paperwork. The Terms and Privacy pages still carry unfilled placeholders where the domain, the pharmacy list and the phone number belong, and they name no operating entity at all; the legal name appears only in the Help Center and the About page. The About page says there are no membership fees while the Terms require an automatically renewing monthly membership, and the checkout showed no membership line, so which governs is unresolved. Nothing is refundable once medication ships.

Does the drug work? (Separate from the provider)

Judge the seller on price, disclosure and oversight; judge the molecule on its trials. Tirzepatide's are strong — roughly 15% to 21% of body weight over 72 weeks in SURMOUNT-1³, and better than semaglutide head to head in SURMOUNT-5⁴ — but those were run on the brand product at approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

AHBARx is easy to price and hard to pin down. The $349 is real, visible before you commit anything, and inclusive of the two fees most competitors add later — but the company charging it is named on two pages of a site whose own legal documents are unfinished. If a published price with a named pharmacy is what you want, Alinwell charges $299 and names two compounders with addresses, and Bayan Health is $149 flat at every dose with the consultation inside the figure. Read the ladder against the field in our tirzepatide price index or the ranked best tirzepatide providers list.